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Histocompatibility Complex 
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Abstract. Chickens of the Iowa State S1 line have been 
selected for ability to regress Rous sarcoma virus-induced 
(RSV) tumors, humoral immune response to GAT (lr-
GAT), and erythrocyte antigen B. Sub lines homozygous at 
the major histocompatibility complex (MHC), as well as 
F1 heterozygotes and F2 segregants, were tested for 
resistance to fowl cholera by challenge with Pasteurella 
multocida strain X73. Control of the response at high doses 
was associated in a preliminary study with Ir-GA T and 
response to RSV tumors. Genetic control of resistance to 
low doses of P. multocida was demonstrated via sublines 
and F2 segregants to be linked with genes of the B-G 
region. Thus, genetic control of resistance to fowl cholera 
in chickens after exposure to Pasteurella multocida was 
shown to be linked to the major histocompatibility B com-
plex, in this first demonstration ofMHC-linked resistance 
to bacterial disease challenge. 
Introduction 
Resistance to many diseases in chickens has been shown to 
be under genetic control associated with the major 
histocompatibility B complex (MHC) (Bacon et al. 1981, 
Briles et al. 1983, Clare et al. 1986, Collins et al. 1977, 
Schierman et al. 1977). The etiological agents involved in 
the studies were viral or parasitic nonbacterial pathogens. 
To our knowledge, there have been no reports of resistance 
to bacterial disease challenge linked to the MHC in 
chickens. 
The bacterium Pasteurella multocida causes fowl 
cholera, a contagious disease affecting both domesticated 
and wild birds. F ow 1 cholera usually appears as a septicem-
ic disease with high morbidity and mortality (Heddleston 
and Rhoades 1978). Pathogenicity of P. multocida in rela-
tion to fowl cholera is variable, depending on the strain of 
P. multocida, the host species, variations within the strain 
or host, and conditions of contact between the two. 
The purpose of this research was to investigate genetic 
control of resistance to fowl cholera by comparing 
resistance of chicken lines of defined MHC composition 
after exposure to P. multocida strain X73. 
Materials and Methods 
Experimental animals. All chickens used in this study were White 
Leghorns of the Iowa State S 1line, bred and maintained at the Iowa State 
University Poultry Research Facility. This is a partially inbred line with 
an overall inbreeding coefficient of 40% (Cheng 1985). The S1line is 
maintained in eight sublines with deliberate segregation for the serologi-
cally detectable erythrocyte antigen B blood group (Ea-B); humoral im-
mune response to the random synthetic amino acid polymer, glutamic 
acid-alanine-tyrosine (lr-GAT); and response to Rous sarcoma virus-
induced (RSV) tumor growth. Ea-B was identified in all breeders by 
microhemagglutination with alloantisera. The typing sera selected for use 
in this study identified only B-G, not B-F, antigens on erythrocytes (data 
not shown) and thus served as a marker for the B-G region. Ir-GAT was 
determined by radioimmunoassay (Pevzner et al. 1978). The Ir-GATgene 
has been shown to be a distinct immune response (lr) gene, separate from 
theEa-B loci, but associated with the chicken MHC (Pevzner eta!. 1978, 
Benedict eta!. 1975). The Ir-GATlocus is hypothesized to serve as a mar-
ker for the B-L region in the three-locus model of the chicken MHC (Pink 
et al. 1977, Nordskog eta!. 1987). Response to RSV tumors was evaluated 
in sibs ofbreeders after inoculation with Bryan high-titer subgroup A RSV 
(kindly provided by Dr. L. B. Crittenden, Regional Poultry Research 
Laboratory, East Lansing, Michigan). A gene exerting major control over 
RSV tumor regression has been mapped to the B-Fregion (Plachy and Vil-
helmova 1984) although non-MHC genetic influence is also known (Col-
lins and Zsigray 1984, Gilmour eta!. 1986). It is not positively known for 
the Slline whether the RSV response is determined primarily by MHC 
or non-MHC genes, but previous data suggest that the B-F region plays 
an important role in RSV tumor response in this line (Gebriel and Nord-
skog 1983). The eight sublines represent all possible triple homozygous 
genotypes for each of these loci: Ea-B, B1 or B19; Ir-GAT, High (H) or 
Low (L); RSV response, regressor (R) or progressor (P). The MHC 
homozygous sublines were mated in all appropriate combinations to 
produce an MHC-heterozygous F 1 generation. The F1 birds were mated 
inter se to produce an F2 generation consisting of the eight MHC 
homozygous types plus MHC-heterozygous chicks. Each of the eight 
MHC homozygous sublines, as well as F 1 and F2 generations, were test-
ed. Experimental chicks were raised in wire-floored heated brooders with 
ad libitum access to food and water. Experimental chicks received no vac-
cinations, but were hatched from eggs laid by hens receiving vaccinations 
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Table 1. Chick survival after challenge of MHC-defined sub lines with high doses of Pasteurella multocida 
Locus Allelet n 
Ea-B 19 135 
129 
2 
X 
Ir-GAT H 139 
L 125 
2 
X 
R-Rs-1 R 133 
p 131 
2 
X 
* P<0.05; ** P<O.Ol; *** P<0.005 
t Effects of other loci averaged equally over each allele 
* Number surviving (percent surviving) 
Days post inoculation 
2 
15(11%)* 12 (9%) 
18 (14%) 12 (9%) 
0.39 0.01 
7 (5%) 4 (3%) 
26 (21 %) 20 (16%) 
11.33*** 10.27*** 
26 (20%) 19 (14%) 
7 (5%) 5 (4%) 
9.56*** 6.80** 
285 
4 7 
12 (9%) 3 (2%) 
10 (8%) 5 (4%) 
0.09 0.48 
4 (3%) 0 (0%) 
18 (14%) 8 (6%) 
8.54*** 6.78** 
18 (14%) 8 (6%) 
4 (3%) 0 (0%) 
7.36** 6.26* 
for Marek's disease, infectious bronchitis, Newcastle's disease, and fowl 
pox. 
determined by subjecting mortality data to chi-square analysis, testing the 
hypothesis that disease resistance was independent of MHC haplotype. 
Results 
Disease resistance challenge. Three-week-old chicks were injected in-
tramuscularly with P. multocida strain X73 [a highly virulent strain origi-
nally isolated from a chicken (Heddleston and Halll958)]. Challenge in-
ocula were prepared and numbers of organisms were estimated as 
previously described (Brodgen eta!. 1978). A plate count method was 
used for final quantitation. (Inocula were kindly provided by Dr. K. R. 
Rhoades, NADC, Ames, Iowa.) Three doses were used in each trial, with 
one third of each genetic group receiving each dose. Each trial, except the 
initial high-dose trial, was replicated. Mortality was recorded at 24-h in-
tervals after challenge, terminating at 1 week. Statistical significance was 
Resistance to high doses of P. multocida. In a preliminary 
study, 264 chicks of the 8 triple homozygous MHC haplo-
types of the Slline were challenged with high doses of P. 
multocida. One third of the chicks of each haplotype 
received one each of three doses ( 510, 5100, or 51 000 bac-
Table 2. Chick survival after challenge of MHC-defined sub lines with low doses of Pasteurella multocida t 
Locus Allele* n Days post inoculation 
2 4 7 
Ea-B 19 369 125 (34%)11 82 (22%) 64 (17%) 55 (15%) 
382 197(52%) 145 (38%) 135 (35%) 124 (32%) 
2 23.99*** 22.04*** 31.21 *** 31.86*** X 
Ir-GAT H 352 134 (38%) 95 (27%) 83 (23%) 74 (21 %) 
L 399 188 (47%) 132 (33%) 116 (29%) 105 (26%) 
2 6.25* 3.29 3.90 2.39 X 
R-Rs-1 R 362 150 (41 %) 103 (28%) 91 (25%) 79 (22%) 
p 389 172 (44%) 124 (32 %) 108 (28%) 100 (26%) 
2 0.59 1.04 0.66 1.56 X 
t Doses used (mean number of bacteria/inoculum), replicate 1: 3, 16.5, 165; replicate 2: 5.4, 16.3, 163 
* Effects of other loci averaged equally over each allele 
II Number surviving (percent surviving) 
* P<0.05; *** P<0.005 
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Table 3. Chick survival after challenge of MHC-heterozygous F 1 chicks with low doses of Pasteurella multocida* 
Locus Allelet. * n Days post inoculation 
2 
Ea-B 19 265 173 (65%)11 141 (53%) 
267 188 (70%) 149 (56%) 
2 1.60 0.36 X 
Ir-GAT H 274 191 (70%) 150 (55%) 
L 258 170 (66%) 140 (54%) 
2 0.89 O.Ql X 
R-Rs-1 R 271 182 (67%) 153 (56%) 
p 261 177(68%) 137 (52%) 
2 0.03 0.84 X 
*Doses used (mean number of bacteria/inoculum), replicate 1: 2.6, 8, 260; replicate 2: 11, 33, 1100 
t Indicates allele contributed by sire to MHC-heterozygous progeny 
* Effects of other loci averaged equally over each allele 
II Number surviving (percent surviving) 
S. J. Lamont et al. 
4 7 
130 (49%) 111 (42%) 
129 (48%) 113 (42%) 
0.03 0.01 
133 (49%) 111(40%) 
126 (49%) 113 (44%) 
0.00 0.59 
135 (50%) 113 (42%) 
124(48%) 111 (42%) 
0.28 0.04 
teria/inoculum). Although mortality was higher with in-
creasing doses, genetic associations with mortality did not 
differ between the doses used in this trial; results of the 
three doses were therefore pooled for presentation (Table 
1). Acute mortality at the high P. multocida doses was ex-
tremely severe, with only 13% of the chicks surviving 24 
h postchallenge and only 3% surviving 1 week. Resistance 
to Pasteurella-induced mortality was associated with both 
immune response to GAT and response to RSV -induced 
tumors. Only chicks of the Ir-GAT 10w, RSV tumor regres-
sor sub line survived to 1 week postchallenge. The B-G an-
tigen had no observed association with P. multocida 
resistance at high challenge doses. 
Resistance to low doses of P. multocida. Because mortality 
was so severe at the high doses used in the preliminary trial, 
Table 4. Chick survival after challenge of F2 chicks with low doses of Pasteurella multocida t 
Locus Allele* n Days post inoculation 
2 4 7 
Ea-B 19 232 82 (35%)11 31 (13%) 21 (9%) 14 (6%) 
205 93 (45%) 44 (21 %) 31 (15%) 25 (12%) 
2 4.56* 5.03* 3.83* 5.07* X 
Ir-GAT H 233 98(42%) 38 (16%) 26 (11 %) 19 (8%) 
L 204 77 (38%) 37 (18%) 26 (13%) 20 (10%) 
2 0.84 0.26 0.26 0.36 X 
R-Rs-1 R 228 87 (38%) 42 (18%) 29 (13%) 24 (11 %) 
p 209 88 (42%) 33 (16%) 23 (11 %) 15 (7%) 
2 0.71 0.53 0.31 1.50 X 
All three hetero- 75 26 (35%) 14 (19%) 9 (12%) 5 (7%) 
zygous combinations 
t Doses used (mean number of bacteria/inoculum), replicate 1: 16, 48, 480; replicate 2: 9.6, 32.1, 321 
* Effects of other loci averaged equally over each allele 
II Number surviving (percent surviving) 
* P<0.05 
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subsequent trials were conducted at a much lower dose 
range. Except for one instance, all doses used in the low-
dose trial were less than the lowest dose in the preliminary 
trial. Although survival increased at lower doses, genetic 
associations in the low-dose trial did not change with 
dosage, and there also were no differences between repli-
cates; doses and replicates were therefore pooled for 
presentation. 
MHC homozygous sublines. Table 2 shows the genetic as-
sociations of MHC regions with survival after low-dose 
Pasteurella challenge. Total survival to 24 h postchallenge 
was 43% and to 1 week, 24%. Highly significant associa-
tion (P < 0. 005) was demonstrated between survival and 
B-G antigen, with more chicks surviving that were 
homozygous B1 B1 than B19B19• Ir-GAT was associated 
with survival only at day 1 postchallenge, and the RSV 
tumor response was not associated with survival at any 
period after low-dose P. multocida challenge. 
MHC heterozygous F1 chicks. Sires of each of the eight 
MHC homozygous sub lines were mated with dams of the 
appropriate haplotype to produce MHC-heterozygous 
progeny. Total survival to 24 h postchallenge was 68% and 
to 1 week, 42% (Table 3). No effect was seen due to mater-
nal or paternal origin of specific MHC regions in the F1 
chicks. 
MHC homozygous and heterozygous F2 chicks. Table 4 
shows the genetic associations of MHC regions with sur-
vival ofF2 chicks after challenge with low-dose Pasteurel-
la multocida. Total survival was 40% at 24 h postchallenge 
and 9% at 1 week postchallenge. Results with F2 chicks 
confirm the genetic associations of the B-G antigen with 
resistance to low dose P. multicida previously demonstrat-
ed in the MHC sub line trial. Homozygous B1 B1 chicks 
demonstrated significantly higher resistance than B19B19 
chicks, definitively linking B-G antigen with cholera 
resistance. 
Discussion 
In our preliminary experiment, high doses of P. multocida 
were used to challenge 3-week-old chicks because previ-
ous reports (Heddleston 1962, Hungerford 1968) indicated 
that young chickens were relatively resistant to infection, 
although the difference in susceptibility was slight after ex-
posure to the X73 strain. The doses of P. multocida strain 
X73 used in our study, however, were sufficient to cause 
87% mortality with the first 24 h. This high susceptibility 
may be due to the extreme virulence of the X73 strain, the 
route of exposure (intramuscular injection), or the genetic 
constitution of the partially inbred chickens. 
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In the preliminary experiment in which high doses of P. 
multocida were used, resistance to fowl cholera was as-
sociated with the MHC regions controlling response to 
RSV tumors and GAT immunization. In the rest of the 
study, however, in which low doses were used, resistance 
was associated with the B-G region. B1 B1 chicks of subline 
and F2 segregant populations were more resistant than 
B19B19 chicks, regardless of their Ir-GAT or RSV 
response genotype. From these results, we conclude that 
resistance to P. multocida was genetically controlled by 
genes within or closely linked to the B-G region of the 
MHC in chickens. The exact chromosomal locations of 
recombinations defining the eight MHC haplotypes in this 
line are not known. Work in progress to define the MHC 
of the Slline at the DNA level, however, suggests that the 
B-G region bears more homology with class II (immune 
response) genes than do either the B-F or B-L regions, as 
defined by RSV -response and Ir-GAT, respectively (J. Pit-
covski, C. Warner, and S. J. Lamont, unpublished data). 
Thus, immune response genes determining resistance to 
fowl cholera may be associated with B-G in this line. 
The observed difference in genetic control of immune 
response at different dosage levels is not without prece-
dent. Gross (1979) presented data that indicated dose X 
strain interactions in sheep red blood cell (SRBC) antibody 
levels of chicken stocks divergently selected for cor-
ticosterone response to stress. Schat and co-workers 
(1981) reported that challenge with highly oncogenic 
Marek's disease (MD) virus isolates caused such high MD 
incidence that differentiation of genetic resistance levels 
was not possible, as it was with less oncogenic isolate 
challenge. The data presented in the present study may in-
dicate extreme dose X genotype interactions. For commer-
cial applications, the genetic association seen at lower 
dosages, which would most closely resemble field ex-
posure levels, would be most important. 
The complexity of a bacterial antigen such as P. mul-
tocida dictates that numerous host defense systems must be 
involved in resistance. As such, it is unlikely that a single 
gene could control total genetic resistance to a bacterium 
(Skamene 1980). There are examples, however, of genetic 
control of resistance to bacterial challenge in chickens. 
Gross and co-workers (1980) showed that lines selected for 
high or low agglutinin response to SRBC differed when 
challenged with Escherichia coli. Interestingly, the high 
responders to SRBC were poor responders to bacterial 
challenge. In the present study, chicks with high antibody 
response to GAT were more susceptible to high dose P. 
multocida mortality. These two examples suggest that 
selection for high response to test antigens does not neces-
sarily imply good response in disease challenge situations. 
The Iowa State S I line of chickens has been developed 
specifically for immunogenetic studies to investigate the 
structure and function of the avian MHC. Early studies us-
ing the S I line investigated effects ofB blood groups on egg 
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production, mortality (Nordskog et al. 1973), and immune 
response (Pevzner et al. 197 5). B1 B1 pullets had signifi-
cantly higher adult mortality and lower antibodies to 
Salmonella pullorum bacteria than did B1 heterozygotes. 
The S 1 line at the time of the early studies segregated for 
four B alleles, B1, If, B19, and B21 , and was mated in a 
scheme to avoid sub line formation and minimize inbreed-
ing. Subsequent to the time of these studies, the S 1line was 
mated to form eight sublines, deliberately segregating 
birds forEa-B, Ir-GAT, andRSV response(Cheng 1985). 
The present study represents one of a series designed to in-
vestigate effects of various MHC regions on disease 
resistance and immune response. This study demonstrates 
MHC linkage with resistance to the bacterium P. multoci-
da; B1B1 chicks were more resistant than B19B19 chicks to 
fowl cholera. In other recent studies with the Iowa StateS 1 
line, resistance to Marek's disease also was associated with 
the B1B1 blood type (Steadham et al. 1987). SRBC titer 
also has been associated with the B-G region of the MH C, 
with B1 B1 chicks having higher antibody responses to 
SRBC (Kim et al. 1986). In contrast, reticuloendothelial 
activity level was not associated with B-G but with ability 
to regress RSV tumors (Lamont 1986). These studies com-
bine to support the growing volume of evidence that as-
signs the MHC a major role in disease resistance and im-
mune response in chickens. 
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